- 04 Jul,2025
- 03 Jul,2025
- 02 Jul,2025
- 01 Jul,2025
- 30 Jun,2025
- 28 Jun,2025
- 27 Jun,2025
- 26 Jun,2025
- 25 Jun,2025
- 24 Jun,2025
- 23 Jun,2025
- 21 Jun,2025
- 20 Jun,2025
- 19 Jun,2025
- 18 Jun,2025
- 17 Jun,2025
- 16 Jun,2025
- 14 Jun,2025
- 13 Jun,2025
- 12 Jun,2025
- 11 Jun,2025
- 09 Jun,2025
- 07 Jun,2025
- 06 Jun,2025
- 05 Jun,2025
- 04 Jun,2025
- 03 Jun,2025
- 02 Jun,2025
- 31 May,2025
- 30 May,2025
- 29 May,2025
- 28 May,2025
- 27 May,2025
- 26 May,2025
- 23 May,2025
- 22 May,2025
- 21 May,2025
- 20 May,2025
- 19 May,2025
- 17 May,2025
- 16 May,2025
- 15 May,2025
- 14 May,2025
- 13 May,2025
- 12 May,2025
- 10 May,2025
- 09 May,2025
- 08 May,2025
- 07 May,2025
- 06 May,2025
- 05 May,2025
- 03 May,2025
- 02 May,2025
- 01 May,2025
- 30 Apr,2025
- 29 Apr,2025
- 28 Apr,2025
- 26 Apr,2025
- 25 Apr,2025
- 24 Apr,2025
- 23 Apr,2025
- 22 Apr,2025
- 21 Apr,2025
- 17 Apr,2025
- 16 Apr,2025
- 15 Apr,2025
- 14 Apr,2025
- 11 Apr,2025
- 09 Apr,2025
- 08 Apr,2025
- 07 Apr,2025
- 05 Apr,2025
- 03 Apr,2025
- 02 Apr,2025
- 01 Apr,2025
- 31 Mar,2025
- 29 Mar,2025
- 28 Mar,2025
- 27 Mar,2025
- 20 Mar,2025
- 19 Mar,2025
- 18 Mar,2025
- 07 Feb,2025
- 03 Feb,2025
- 01 Feb,2025
- 31 Jan,2025
- 30 Jan,2025
- 29 Jan,2025
- 28 Jan,2025
- 27 Jan,2025
- 25 Jan,2025
- 24 Jan,2025
- 23 Jan,2025
- 22 Jan,2025
- 21 Jan,2025
- 20 Jan,2025
- 18 Jan,2025
- 17 Jan,2025
- 16 Jan,2025
- 15 Jan,2025
- 14 Jan,2025
- 13 Jan,2025
- 11 Jan,2025
- 10 Jan,2025
- 09 Jan,2025
- 07 Jan,2025
- 04 Jan,2025
- 03 Jan,2025
- 01 Jan,2025
- 30 Dec,2024
- 28 Dec,2024
- 14 Dec,2024
- 13 Dec,2024
- 12 Dec,2024
- 11 Dec,2024
- 10 Dec,2024
- 09 Dec,2024
- 07 Dec,2024
- 06 Dec,2024
- 05 Dec,2024
- 04 Dec,2024
- 03 Dec,2024
- 02 Dec,2024
- 30 Nov,2024
- 29 Nov,2024
- 27 Nov,2024
- 26 Nov,2024
- 21 Nov,2024
- 20 Nov,2024
- 19 Nov,2024
- 18 Nov,2024
- 16 Nov,2024
- 14 Nov,2024
- 13 Nov,2024
- 09 Nov,2024
- 08 Nov,2024
- 07 Nov,2024
- 06 Nov,2024
- 05 Nov,2024
- 04 Nov,2024
- 02 Nov,2024
- 30 Oct,2024
- 29 Oct,2024
- 26 Oct,2024
- 25 Oct,2024
- 24 Oct,2024
- 22 Oct,2024
- 21 Oct,2024
- 19 Oct,2024
- 17 Oct,2024
- 16 Oct,2024
- 15 Oct,2024
- 14 Oct,2024
- 12 Oct,2024
- 11 Oct,2024
- 10 Oct,2024
- 09 Oct,2024
- 08 Oct,2024
- 05 Oct,2024
- 04 Oct,2024
- 03 Oct,2024
- 02 Oct,2024
- 01 Oct,2024
- 30 Sep,2024
- 28 Sep,2024
- 27 Sep,2024
- 26 Sep,2024
- 25 Sep,2024
- 24 Sep,2024
- 23 Sep,2024
- 21 Sep,2024
- 20 Sep,2024
- 19 Sep,2024
- 18 Sep,2024
- 17 Sep,2024
- 16 Sep,2024
- 14 Sep,2024
- 13 Sep,2024
- 12 Sep,2024
- 11 Sep,2024
- 10 Sep,2024
- 07 Sep,2024
- 06 Sep,2024
- 05 Sep,2024
- 04 Sep,2024
- 03 Sep,2024
- 02 Sep,2024
- 31 Aug,2024
- 30 Aug,2024
- 29 Aug,2024
- 28 Aug,2024
- 27 Aug,2024
- 26 Aug,2024
- 24 Aug,2024
- 23 Aug,2024
- 22 Aug,2024
- 21 Aug,2024
- 20 Aug,2024
- 19 Aug,2024
- 17 Aug,2024
- 16 Aug,2024
- 14 Aug,2024
- 13 Aug,2024
- 12 Aug,2024
- 10 Aug,2024
- 09 Aug,2024
- 08 Aug,2024
- 07 Aug,2024
- 06 Aug,2024
- 05 Aug,2024
- 03 Aug,2024
- 02 Aug,2024
- 01 Aug,2024
- 31 Jul,2024
- 30 Jul,2024
- 29 Jul,2024
- 27 Jul,2024
- 26 Jul,2024
- 25 Jul,2024
- 24 Jul,2024
- 23 Jul,2024
- 22 Jul,2024
- 20 Jul,2024
- 19 Jul,2024
- 18 Jul,2024
- 17 Jul,2024
- 16 Jul,2024
- 15 Jul,2024
- 13 Jul,2024
- 12 Jul,2024
- 11 Jul,2024
- 10 Jul,2024
- 09 Jul,2024
- 08 Jul,2024
- 06 Jul,2024
- 05 Jul,2024
- 04 Jul,2024
- 03 Jul,2024
- 02 Jul,2024
- 01 Jul,2024
- 29 Jun,2024
- 28 Jun,2024
- 27 Jun,2024
- 25 Jun,2024
- 22 Jun,2024
- 21 Jun,2024
- 20 Jun,2024
- 15 Jun,2024
- 14 Jun,2024
- 13 Jun,2024
- 12 Jun,2024
- 11 Jun,2024
- 10 Jun,2024
- 08 Jun,2024
- 07 Jun,2024
- 06 Jun,2024
- 05 Jun,2024
- 04 Jun,2024
- 03 Jun,2024
- 01 Jun,2024
- 30 May,2024
- 28 May,2024
- 24 May,2024
- 23 May,2024
- 22 May,2024
- 21 May,2024
- 20 May,2024
- 18 May,2024
- 17 May,2024
- 16 May,2024
- 15 May,2024
- 09 May,2024
- 06 May,2024
- 04 May,2024
- 03 May,2024
- 02 May,2024
- 01 May,2024
- 30 Apr,2024
- 26 Apr,2024
- 25 Apr,2024
- 24 Apr,2024
- 23 Apr,2024
- 22 Apr,2024
- 20 Apr,2024
- 19 Apr,2024
- 18 Apr,2024
- 17 Apr,2024
- 16 Apr,2024
- 15 Apr,2024
- 13 Apr,2024
- 12 Apr,2024
- 10 Apr,2024
- 09 Apr,2024
- 06 Apr,2024
- 05 Apr,2024
- 03 Apr,2024
- 02 Apr,2024
- 01 Apr,2024
- 30 Mar,2024
- 29 Mar,2024
- 28 Mar,2024
- 27 Mar,2024
- 26 Mar,2024
- 23 Mar,2024
- 22 Mar,2024
- 21 Mar,2024
- 20 Mar,2024
- 19 Mar,2024
- 18 Mar,2024
- 16 Mar,2024
- 15 Mar,2024
- 14 Mar,2024
- 13 Mar,2024
- 12 Mar,2024
- 09 Mar,2024
- 08 Mar,2024
- 07 Mar,2024
- 06 Mar,2024
- 05 Mar,2024
- 04 Mar,2024
- 02 Mar,2024
- 01 Mar,2024
- 29 Feb,2024
- 28 Feb,2024
- 27 Feb,2024
- 24 Feb,2024
- 23 Feb,2024
- 22 Feb,2024
- 21 Feb,2024
- 20 Feb,2024
- 19 Feb,2024
- 17 Feb,2024
- 16 Feb,2024
- 15 Feb,2024
- 14 Feb,2024
- 12 Feb,2024
- 10 Feb,2024
- 09 Feb,2024
- 07 Feb,2024
- 06 Feb,2024
- 01 Feb,2024
- 31 Jan,2024
- 30 Jan,2024
- 24 Jan,2024
- 22 Jan,2024
- 16 Jan,2024
- 15 Jan,2024
- 13 Jan,2024
- 12 Jan,2024
- 11 Jan,2024
- 10 Jan,2024
- 09 Jan,2024
- 08 Jan,2024
- 05 Jan,2024
- 03 Jan,2024
- 02 Jan,2024
- 30 Dec,2023
- 29 Dec,2023
- 27 Dec,2023
- 25 Dec,2023
- 23 Dec,2023
- 22 Dec,2023
- 09 Dec,2023
- 08 Dec,2023
- 07 Dec,2023
- 06 Dec,2023
- 05 Dec,2023
- 04 Dec,2023
- 02 Dec,2023
- 01 Dec,2023
- 29 Nov,2023
- 28 Nov,2023
- 27 Nov,2023
- 26 Nov,2023
- 25 Nov,2023
- 24 Nov,2023
- 23 Nov,2023
- 22 Nov,2023
- 21 Nov,2023
- 20 Nov,2023
- 19 Nov,2023
- 17 Nov,2023
- 14 Nov,2023
- 11 Nov,2023
- 25 Oct,2023
- 19 Oct,2023
- 14 Jan,2023
- 01 Jan,1970
- 12 Dec,0024
Current Affairs-Topics
Rwanda's 2024 Election: Paul Kagame's Victory with 99% votes
President Paul Kagame won 99.15% of votes in the July 15, 2024 presidential and legislative elections, with 9.5 million Rwandans registered. Kagame, 66, has been in power since 1994 and has won previous elections with over 93% of votes. |
Election Results and Process
- President Paul Kagame won 99.15% of votes in provisional results
- Election held in Rwanda on July 15, 2024
- Two opponents collectively received less than 1% of votes:
- Frank Habineza (Democratic Green Party): 0.53%
- Philippe Mpayimana (Independent): 0.32%
- 79% of ballots counted in provisional results
- Final results expected by July 27, 2024
- 9.5 million Rwandans registered to vote out of 14 million population
- Simultaneous presidential and legislative elections for the first time
- National Electoral Commission declared the process "safe and transparent"
Paul Kagame's Political Career and Influence
- Age: 66 years old
- In power since 1994, first as de facto leader, then as president since 2000
- Won previous elections with over 93% of votes in 2003, 2010, and 2017
- Led the Rwandan Patriotic Front (RPF) that ended the 1994 genocide
- Constitutional amendments allow him to potentially rule until 2034
- Credited with rebuilding Rwanda after the genocide
- Praised for impressive economic growth (7.2% average GDP growth from 2012-2022)
- Criticized for authoritarian rule and suppression of opposition
- Accused of meddling in neighboring Democratic Republic of Congo
Election Context and Controversies
- Only two challengers allowed to run against Kagame
- Stronger critics blocked from running:
- Bernard Ntaganda and Victoire Ingabire: previous convictions disqualified them
- Diane Rwigara: barred due to paperwork issues
- Amnesty International raised concerns about restrictions on political opposition
- Reports of threats, arbitrary detentions, and enforced disappearances
- Imbalance in campaign visibility between Kagame and opponents
- UN report accuses Rwanda of supporting M23 rebels in eastern Congo
Rwanda's Current Situation and Future Outlook
- 65% of the population under 30 years old
- Kagame is the only leader most Rwandans have known
- Economic progress: GDP growth of 7.2% per year between 2012 and 2022
- Poverty concerns: World Bank reports almost half the population lives on less than $2.15 a day
- Parliamentary election held simultaneously:
- 589 candidates competing for 80 seats
- 53 seats elected by universal suffrage
- 27 seats reserved for women, youth, and people with disabilities
- Previous parliament dominated by RPF (40 seats) and allies (11 seats)
- Kagame's supporters praise his leadership in development and security
- Critics worry about lack of political freedom and human rights issues
More Related Articles
SEBI Action on Jane Street
In one of the most significant regulatory crackdowns in Indian financial history, the SEBI action on Jane Street has grabbed headlines and raised critical discussions around foreign investment, ma
Rwanda-Congo Peace Deal
In a major diplomatic development, Rwanda and the Democratic Republic of Congo (DRC) signed the historic Rwanda-Congo peace deal in 2025.
This US-brokered peace agreement aims to end deca
India Rejects SCO Joint Statement
India rejects SCO joint statement – this powerful decision echoed globally after India’s Defence Minister refused to sign the final declaration at the SCO 2025 Summit in Qingdao, China
Unsafe Generic Chemotherapy Drugs
Recent investigations have uncovered serious quality issues in generic chemotherapy drugs used for cancer treatment across more than 100 countries.
This has raised alarms over the safety, effe
NATO Defence Spending 2025
The NATO defence spending 2025 summit has marked a historic turning point in the alliance’s approach to global defence and military funding.
Under the leadership of former U.S. President
Operation Bashayer Al-Fath
On June 23, 2025, the Middle East witnessed a major escalation as Iran launched Operation Bashayer Al-Fath, a powerful missile assault targeting the US Al-Udeid Air Base in Qatar.
This developm
GENIUS Act 2025 Highlights
The GENIUS Act 2025, passed by the US Senate in June 2025, represents a significant legislative step in cryptocurrency regulation, with a widespread impact on stablecoins, digi
US-Iran Nuclear Conflict 2025
On June 22, 2025, the United States launched targeted airstrikes on three major Iranian nuclear facilities—Fordow, Isfahan, and Natanz—escalating what is now widely recognized as the U
Iran Uranium Enrichment
The ongoing tension between Iran, Israel, and the United States has taken a serious turn, primarily due to Iran's uranium enrichment issue. The situation surrounding Iran’s Fordow nuclea
Yeztugo HIV Injection
In a historic development in the fight against HIV, the United States Food and Drug Administration (US FDA) has approved Yeztugo HIV injection—a revolutionary drug for the long-acting preven